EpCAM×CD3 possesses potent antitumor activity in vitro by inducing secretion of interleukins and cytokines by pre-activated lymphocytes in the presence of EpCAM-expressing RB tumor cells. This evidence concerns the gene EPCAM and retinoblastoma.